The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.
Patrick McDaneld, PharmD, BCIDP
Advertisement
McDaneld is an infectious diseases pharmacist with 10 years of clinical experience, primarily focused on immunocompromised patients and antimicrobial resistance. He is currently an infectious disease medical science liaison for bioMérieux.
Articles by Patrick McDaneld, PharmD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
2
Developing a COVID-19 Vaccine Alternative
3
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
4
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
5
